<DOC>
	<DOCNO>NCT00776477</DOCNO>
	<brief_summary>Clopidogrel antiplatelet agent effective reduce intimal hyperplasia animal model thrombosis.Several large clinical trial demonstrate clopidogrel aspirin reduce ischemic event mortality patient atherosclerotic disease , therefore combination two antiplatelets might useful prevent patient receive coronary artery bypass graft surgery Saphenous vein graft disease . aim study estimate safety efficacy clopidogrel aspirin therapy versus aspirin alone patient CABG .</brief_summary>
	<brief_title>The Clopidogrel Aspirin After Surgery Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Patients undergo primary multivessel CABG least two saphenous vein graft , without use cardiopulmonary bypass . Emergency surgery Valve surgery Redo CABG Left ventricle ejection fraction &lt; 30 % Preoperative use clopidogrel ( exception current admission ) Preoperative use warfarin Allergy aspirin clopidogrel History cerebrovascular accident History severe liver disease Morbid obesity Current malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>